These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7501395)

  • 81. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia.
    Langeveld TP; Drost HA; Baatenburg de Jong RJ
    Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):280-4. PubMed ID: 9557760
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Does cognitive function influence alaryngeal speech rehabilitation?
    Ho TP; Gray J; Ratcliffe AA; Rees S; Rockey J; Wight RG
    Head Neck; 2006 May; 28(5):413-9. PubMed ID: 16287133
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Multivariable analysis of risk factors for enlargement of the tracheoesophageal puncture after total laryngectomy.
    Hutcheson KA; Lewin JS; Sturgis EM; Risser J
    Head Neck; 2012 Apr; 34(4):557-67. PubMed ID: 21692129
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The management of advanced carcinoma of the tongue by total glossectomy without laryngectomy.
    Effron MZ
    Trans Pa Acad Ophthalmol Otolaryngol; 1981; 34(2):158-63. PubMed ID: 7314209
    [No Abstract]   [Full Text] [Related]  

  • 86. The Amatsu's tracheoesophageal shunt: analysis of 84 cases.
    Zocratto OB; Vieira MB; Maia AF; Ferreira AC; Larangeira LT; Penido MN; Silva LL
    J Voice; 2014 Jul; 28(4):512-4. PubMed ID: 24321585
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
    Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
    Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Functional utility and oncologic safety of near-total laryngectomy with tracheopharyngeal speech shunt in a Third World oncologic center.
    Shenoy AM; Plinkert PK; Nanjundappa N; Premalata S; Arunodhay GR
    Eur Arch Otorhinolaryngol; 1997; 254(3):128-32. PubMed ID: 9112032
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Botulinum toxin treatment for spasmodic dysphonia.
    Kobayashi T; Niimi S; Kumada M; Kosaki H; Hirose H
    Acta Otolaryngol Suppl; 1993; 504():155-7. PubMed ID: 8470525
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion.
    Carruthers J; Stubbs HA
    Can J Neurol Sci; 1987 Feb; 14(1):42-5. PubMed ID: 3815164
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
    Price J; Farish S; Taylor H; O'Day J
    Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Success and predictability of provox prosthesis voice rehabilitation.
    Hotz MA; Baumann A; Schaller I; Zbären P
    Arch Otolaryngol Head Neck Surg; 2002 Jun; 128(6):687-91. PubMed ID: 12049565
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Tracheoesophageal speech failure in the laryngectomee: the role of constrictor myotomy.
    Henley J; Souliere C
    Laryngoscope; 1986 Sep; 96(9 Pt 1):1016-20. PubMed ID: 3747687
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Treatment of facial spasm with Oculinum (C. botulinum toxin).
    Biglan AW; May M
    J Pediatr Ophthalmol Strabismus; 1986; 23(5):216-21. PubMed ID: 3772688
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Voice rehabilitation with the jejunum speech siphon: the biventer rein, a modification for prevention of aspiration].
    Remmert S; Ahrens KH; Sommer K; Müller G; Weerda H
    Laryngorhinootologie; 1994 Feb; 73(2):84-7. PubMed ID: 8161415
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Treatment of hip adductor spasticity with botulinum toxin type B].
    Oechsner M
    Nervenarzt; 2002 Dec; 73(12):1179-82. PubMed ID: 12486568
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Treatment of hemifacial spasm with botulinum toxin. Value of preinjection electromyography abnormalities for predicting postinjection lower facial paresis.
    Angibaud G; Moreau MS; Rascol O; Clanet M
    Eur Neurol; 1995; 35(1):43-5. PubMed ID: 7737246
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Postlaryngectomy voice restoration--a 2-year review.
    Lentin R; Williams G; Sellars SL
    S Afr J Surg; 1995 Dec; 33(4):183-5. PubMed ID: 8677473
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Selective myotomy for voice restoration after total laryngectomy.
    Singer MI; Blom ED
    Arch Otolaryngol; 1981 Nov; 107(11):670-3. PubMed ID: 7295161
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture.
    Gitomer SA; Hutcheson KA; Christianson BL; Samuelson MB; Barringer DA; Roberts DB; Hessel AC; Weber RS; Lewin JS; Zafereo ME
    Head Neck; 2016 Dec; 38(12):1765-1771. PubMed ID: 27394060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.